iRadPulse
@iradpulse.bsky.social
The latest and greatest in Vascular & Interventional Radiology through AI-enhanced summaries.
Posts≠medical advice. Powered by@EvidenceHawk
Posts≠medical advice. Powered by@EvidenceHawk
4/6 By 12 months:
📈 89.5% primary patency
✅ 68.2% improved Rutherford class
🦶 90% low/very low amputation risk (WIfI scores)
✨ No additional major amputations or target lesion revascularizations
#VascularHealth #PatientOutcomes
📈 89.5% primary patency
✅ 68.2% improved Rutherford class
🦶 90% low/very low amputation risk (WIfI scores)
✨ No additional major amputations or target lesion revascularizations
#VascularHealth #PatientOutcomes
March 25, 2025 at 11:06 PM
4/6 By 12 months:
📈 89.5% primary patency
✅ 68.2% improved Rutherford class
🦶 90% low/very low amputation risk (WIfI scores)
✨ No additional major amputations or target lesion revascularizations
#VascularHealth #PatientOutcomes
📈 89.5% primary patency
✅ 68.2% improved Rutherford class
🦶 90% low/very low amputation risk (WIfI scores)
✨ No additional major amputations or target lesion revascularizations
#VascularHealth #PatientOutcomes
3/6 Results at 6 months:
🔹 11.5% primary safety events (1 mortality, 1 major amputation, 1 target lesion revascularization)
🔹 Late lumen loss: 0.7±0.7 mm
🔹 Negligible acute vessel recoil (2.4 mm to 2.3 mm)
🔹 11.5% primary safety events (1 mortality, 1 major amputation, 1 target lesion revascularization)
🔹 Late lumen loss: 0.7±0.7 mm
🔹 Negligible acute vessel recoil (2.4 mm to 2.3 mm)
March 25, 2025 at 11:06 PM
3/6 Results at 6 months:
🔹 11.5% primary safety events (1 mortality, 1 major amputation, 1 target lesion revascularization)
🔹 Late lumen loss: 0.7±0.7 mm
🔹 Negligible acute vessel recoil (2.4 mm to 2.3 mm)
🔹 11.5% primary safety events (1 mortality, 1 major amputation, 1 target lesion revascularization)
🔹 Late lumen loss: 0.7±0.7 mm
🔹 Negligible acute vessel recoil (2.4 mm to 2.3 mm)
2/6 The DEEPER LIMUS study focused on patients with Rutherford class 3 to 5 infrapopliteal artery disease.
Participants underwent vessel preparation with retrievable scaffold therapy followed by sirolimus-coated balloon angioplasty 💉
#InterventionalRadiology #VascularSurgery
Participants underwent vessel preparation with retrievable scaffold therapy followed by sirolimus-coated balloon angioplasty 💉
#InterventionalRadiology #VascularSurgery
March 25, 2025 at 11:06 PM
2/6 The DEEPER LIMUS study focused on patients with Rutherford class 3 to 5 infrapopliteal artery disease.
Participants underwent vessel preparation with retrievable scaffold therapy followed by sirolimus-coated balloon angioplasty 💉
#InterventionalRadiology #VascularSurgery
Participants underwent vessel preparation with retrievable scaffold therapy followed by sirolimus-coated balloon angioplasty 💉
#InterventionalRadiology #VascularSurgery
1/6 🚨 89.5% primary patency achieved in retrievable scaffold therapy with sirolimus-coated balloon angioplasty for infrapopliteal lesions! 🩺🌟
Check out the latest findings from CVIR in their DEEPER LIMUS study👇
#Infrapopliteal #Angioplasty #VascularHealth
Check out the latest findings from CVIR in their DEEPER LIMUS study👇
#Infrapopliteal #Angioplasty #VascularHealth
March 25, 2025 at 11:06 PM
1/6 🚨 89.5% primary patency achieved in retrievable scaffold therapy with sirolimus-coated balloon angioplasty for infrapopliteal lesions! 🩺🌟
Check out the latest findings from CVIR in their DEEPER LIMUS study👇
#Infrapopliteal #Angioplasty #VascularHealth
Check out the latest findings from CVIR in their DEEPER LIMUS study👇
#Infrapopliteal #Angioplasty #VascularHealth
3/5 Key Findings:
- Technical success: 100%
- PTBDs removed median of 65 days post-procedure
- Median follow-up: 2.8 years
- Outcomes: No bile leakages or re-occlusions observed
- Complications: None reported
#PatientOutcomes #Safety
- Technical success: 100%
- PTBDs removed median of 65 days post-procedure
- Median follow-up: 2.8 years
- Outcomes: No bile leakages or re-occlusions observed
- Complications: None reported
#PatientOutcomes #Safety
March 21, 2025 at 12:00 PM
3/5 Key Findings:
- Technical success: 100%
- PTBDs removed median of 65 days post-procedure
- Median follow-up: 2.8 years
- Outcomes: No bile leakages or re-occlusions observed
- Complications: None reported
#PatientOutcomes #Safety
- Technical success: 100%
- PTBDs removed median of 65 days post-procedure
- Median follow-up: 2.8 years
- Outcomes: No bile leakages or re-occlusions observed
- Complications: None reported
#PatientOutcomes #Safety
2/5 Study Details:
- Participants: 4 patients (mean age 56)
- Background: Right posterior bile duct exclusion and bile leakage after liver/pancreatic surgery or liver transplant
- Method: Fluoroscopy-guided PBNA followed by PTBD
#Hepatology
- Participants: 4 patients (mean age 56)
- Background: Right posterior bile duct exclusion and bile leakage after liver/pancreatic surgery or liver transplant
- Method: Fluoroscopy-guided PBNA followed by PTBD
#Hepatology
March 21, 2025 at 12:00 PM
2/5 Study Details:
- Participants: 4 patients (mean age 56)
- Background: Right posterior bile duct exclusion and bile leakage after liver/pancreatic surgery or liver transplant
- Method: Fluoroscopy-guided PBNA followed by PTBD
#Hepatology
- Participants: 4 patients (mean age 56)
- Background: Right posterior bile duct exclusion and bile leakage after liver/pancreatic surgery or liver transplant
- Method: Fluoroscopy-guided PBNA followed by PTBD
#Hepatology
1/5 🚨 100% technical success in performing percutaneous biliary neo-anastomosis (PBNA) with fluoroscopy guidance!👇
Check out this recent study from CVIR exploring the safety and effectiveness of PBNA for challenging biliary conditions 🧵
#BiliaryIntervention #InterventionalRadiology
Check out this recent study from CVIR exploring the safety and effectiveness of PBNA for challenging biliary conditions 🧵
#BiliaryIntervention #InterventionalRadiology
March 21, 2025 at 12:00 PM
1/5 🚨 100% technical success in performing percutaneous biliary neo-anastomosis (PBNA) with fluoroscopy guidance!👇
Check out this recent study from CVIR exploring the safety and effectiveness of PBNA for challenging biliary conditions 🧵
#BiliaryIntervention #InterventionalRadiology
Check out this recent study from CVIR exploring the safety and effectiveness of PBNA for challenging biliary conditions 🧵
#BiliaryIntervention #InterventionalRadiology
3/6 Results:
📌 Post-transplant HCC recurrence:
• Bridging: 1 patient (3%)
• Downstaging: 4 patients (23.5%)
📌 Disease-free survival at 5 years:
• Bridging: 86%
• Downstaging: 65% (p < 0.05)
#LiverDisease #Chemoembolization
📌 Post-transplant HCC recurrence:
• Bridging: 1 patient (3%)
• Downstaging: 4 patients (23.5%)
📌 Disease-free survival at 5 years:
• Bridging: 86%
• Downstaging: 65% (p < 0.05)
#LiverDisease #Chemoembolization
March 20, 2025 at 12:00 PM
3/6 Results:
📌 Post-transplant HCC recurrence:
• Bridging: 1 patient (3%)
• Downstaging: 4 patients (23.5%)
📌 Disease-free survival at 5 years:
• Bridging: 86%
• Downstaging: 65% (p < 0.05)
#LiverDisease #Chemoembolization
📌 Post-transplant HCC recurrence:
• Bridging: 1 patient (3%)
• Downstaging: 4 patients (23.5%)
📌 Disease-free survival at 5 years:
• Bridging: 86%
• Downstaging: 65% (p < 0.05)
#LiverDisease #Chemoembolization
2/6 Study Focus:
🔍 286 patients undergoing liver transplantation for cirrhosis and early HCC (2006-2021)
🔍 53 received neoadjuvant TACE with doxorubicin-eluting microspheres
🔍 Two groups: Bridging (n=36) and downstaging (n=17)
#TransplantSurgery #Oncology
🔍 286 patients undergoing liver transplantation for cirrhosis and early HCC (2006-2021)
🔍 53 received neoadjuvant TACE with doxorubicin-eluting microspheres
🔍 Two groups: Bridging (n=36) and downstaging (n=17)
#TransplantSurgery #Oncology
March 20, 2025 at 12:00 PM
2/6 Study Focus:
🔍 286 patients undergoing liver transplantation for cirrhosis and early HCC (2006-2021)
🔍 53 received neoadjuvant TACE with doxorubicin-eluting microspheres
🔍 Two groups: Bridging (n=36) and downstaging (n=17)
#TransplantSurgery #Oncology
🔍 286 patients undergoing liver transplantation for cirrhosis and early HCC (2006-2021)
🔍 53 received neoadjuvant TACE with doxorubicin-eluting microspheres
🔍 Two groups: Bridging (n=36) and downstaging (n=17)
#TransplantSurgery #Oncology
1/6 🚨 Only 3% post-transplant recurrence in liver transplants after bridging TACE with doxorubicin-eluting microspheres!
Discover new insights from CVIR on transplant outcomes for HCC patients using this neoadjuvant technique 🧵
#LiverTransplant #HCC #TACE
Discover new insights from CVIR on transplant outcomes for HCC patients using this neoadjuvant technique 🧵
#LiverTransplant #HCC #TACE
March 20, 2025 at 12:00 PM
1/6 🚨 Only 3% post-transplant recurrence in liver transplants after bridging TACE with doxorubicin-eluting microspheres!
Discover new insights from CVIR on transplant outcomes for HCC patients using this neoadjuvant technique 🧵
#LiverTransplant #HCC #TACE
Discover new insights from CVIR on transplant outcomes for HCC patients using this neoadjuvant technique 🧵
#LiverTransplant #HCC #TACE
3/6 Challenges in the transition included:
🔹 Achieving financial independence from diagnostic radiology
🔹 Establishing a robust research program
🔹 Securing dedicated clinical facilities
🔹 Garnering strong institutional support
#HealthcareLeadership #AcademicMedicine
🔹 Achieving financial independence from diagnostic radiology
🔹 Establishing a robust research program
🔹 Securing dedicated clinical facilities
🔹 Garnering strong institutional support
#HealthcareLeadership #AcademicMedicine
March 18, 2025 at 1:00 PM
3/6 Challenges in the transition included:
🔹 Achieving financial independence from diagnostic radiology
🔹 Establishing a robust research program
🔹 Securing dedicated clinical facilities
🔹 Garnering strong institutional support
#HealthcareLeadership #AcademicMedicine
🔹 Achieving financial independence from diagnostic radiology
🔹 Establishing a robust research program
🔹 Securing dedicated clinical facilities
🔹 Garnering strong institutional support
#HealthcareLeadership #AcademicMedicine
2/6 Background: The shift reflects IR's evolution from diagnostic radiology—a transition acknowledged by the 2012 Dual Primary Certificate in Interventional and Diagnostic Radiology by the American Board of Medical Specialties 📈
#MedicalEducation #Radiology
#MedicalEducation #Radiology
March 18, 2025 at 1:00 PM
2/6 Background: The shift reflects IR's evolution from diagnostic radiology—a transition acknowledged by the 2012 Dual Primary Certificate in Interventional and Diagnostic Radiology by the American Board of Medical Specialties 📈
#MedicalEducation #Radiology
#MedicalEducation #Radiology
1/6 🚨 Establishing independence: The University of Miami created its own Department of Interventional Radiology (IR) in 2016, a 3-year journey emphasizing IR's unique role in patient care.
Let's dive into their key achievements and challenges! 👇
#InterventionalRadiology
Let's dive into their key achievements and challenges! 👇
#InterventionalRadiology
March 18, 2025 at 1:00 PM
1/6 🚨 Establishing independence: The University of Miami created its own Department of Interventional Radiology (IR) in 2016, a 3-year journey emphasizing IR's unique role in patient care.
Let's dive into their key achievements and challenges! 👇
#InterventionalRadiology
Let's dive into their key achievements and challenges! 👇
#InterventionalRadiology
5/6 📝 Conclusion: CT-guided RFA shows promise as a safe and effective treatment for resectable pulmonary GGNs, especially when surgery is not an option.
🔗 Read the full study here: doi.org/doi:10.1007...
#PatientCare #Radiology #MedTwitter #GGNs #InterventionalRadiology
🔗 Read the full study here: doi.org/doi:10.1007...
#PatientCare #Radiology #MedTwitter #GGNs #InterventionalRadiology
March 18, 2025 at 12:14 AM
5/6 📝 Conclusion: CT-guided RFA shows promise as a safe and effective treatment for resectable pulmonary GGNs, especially when surgery is not an option.
🔗 Read the full study here: doi.org/doi:10.1007...
#PatientCare #Radiology #MedTwitter #GGNs #InterventionalRadiology
🔗 Read the full study here: doi.org/doi:10.1007...
#PatientCare #Radiology #MedTwitter #GGNs #InterventionalRadiology
3/6 Key Results:
▪️ No local recurrence or distant metastasis in either group over ~2 years follow-up
▪️ RFA group had fewer postoperative complications (Clavien-Dindo classification)
▪️ Significantly lower pleural effusion rates in RFA group (P < 0.001)
#Surgery
▪️ No local recurrence or distant metastasis in either group over ~2 years follow-up
▪️ RFA group had fewer postoperative complications (Clavien-Dindo classification)
▪️ Significantly lower pleural effusion rates in RFA group (P < 0.001)
#Surgery
March 18, 2025 at 12:14 AM
3/6 Key Results:
▪️ No local recurrence or distant metastasis in either group over ~2 years follow-up
▪️ RFA group had fewer postoperative complications (Clavien-Dindo classification)
▪️ Significantly lower pleural effusion rates in RFA group (P < 0.001)
#Surgery
▪️ No local recurrence or distant metastasis in either group over ~2 years follow-up
▪️ RFA group had fewer postoperative complications (Clavien-Dindo classification)
▪️ Significantly lower pleural effusion rates in RFA group (P < 0.001)
#Surgery
2/6 Study Design:
🔹 Bi-center retrospective study
🔹 Patients with resectable pulmonary ground glass nodules (GGNs)
🔹 Compared CT-guided RFA (34 patients) vs. thoracoscopic sublobar resection (37 patients)
🔹 Focus on safety and efficacy outcomes
#InterventionalRadiology
🔹 Bi-center retrospective study
🔹 Patients with resectable pulmonary ground glass nodules (GGNs)
🔹 Compared CT-guided RFA (34 patients) vs. thoracoscopic sublobar resection (37 patients)
🔹 Focus on safety and efficacy outcomes
#InterventionalRadiology
March 18, 2025 at 12:14 AM
2/6 Study Design:
🔹 Bi-center retrospective study
🔹 Patients with resectable pulmonary ground glass nodules (GGNs)
🔹 Compared CT-guided RFA (34 patients) vs. thoracoscopic sublobar resection (37 patients)
🔹 Focus on safety and efficacy outcomes
#InterventionalRadiology
🔹 Bi-center retrospective study
🔹 Patients with resectable pulmonary ground glass nodules (GGNs)
🔹 Compared CT-guided RFA (34 patients) vs. thoracoscopic sublobar resection (37 patients)
🔹 Focus on safety and efficacy outcomes
#InterventionalRadiology
1/6 🚨 CT-guided radiofrequency ablation (RFA) led to significantly fewer postoperative complications in pulmonary GGNs compared to thoracoscopic sublobar resection!
Explore the latest study from CVIR comparing these interventions. 🩺✨
#PulmonaryNodules #RFA
Explore the latest study from CVIR comparing these interventions. 🩺✨
#PulmonaryNodules #RFA
March 18, 2025 at 12:14 AM
1/6 🚨 CT-guided radiofrequency ablation (RFA) led to significantly fewer postoperative complications in pulmonary GGNs compared to thoracoscopic sublobar resection!
Explore the latest study from CVIR comparing these interventions. 🩺✨
#PulmonaryNodules #RFA
Explore the latest study from CVIR comparing these interventions. 🩺✨
#PulmonaryNodules #RFA
4/6 Results:
🔹 21 joints improved to VAS 0-3
🔹 7 joints remained at VAS 4-6
🔹 9 joints showed no improvement (VAS 7-10)
🔹 Minor complication: transient posterior thigh numbness in 2 patients, resolved within 30 days
#VAS #PatientOutcomes
🔹 21 joints improved to VAS 0-3
🔹 7 joints remained at VAS 4-6
🔹 9 joints showed no improvement (VAS 7-10)
🔹 Minor complication: transient posterior thigh numbness in 2 patients, resolved within 30 days
#VAS #PatientOutcomes
March 13, 2025 at 12:00 PM
4/6 Results:
🔹 21 joints improved to VAS 0-3
🔹 7 joints remained at VAS 4-6
🔹 9 joints showed no improvement (VAS 7-10)
🔹 Minor complication: transient posterior thigh numbness in 2 patients, resolved within 30 days
#VAS #PatientOutcomes
🔹 21 joints improved to VAS 0-3
🔹 7 joints remained at VAS 4-6
🔹 9 joints showed no improvement (VAS 7-10)
🔹 Minor complication: transient posterior thigh numbness in 2 patients, resolved within 30 days
#VAS #PatientOutcomes
1/6 🚨 64.5% of patients with great trochanteric pain syndrome (GTPS) showed improvement with LFCA embolization, as per the latest study results.
Check out this new study from CVIR on managing hip pain when conservative treatments fail👇
#GTPS #Embolization
Check out this new study from CVIR on managing hip pain when conservative treatments fail👇
#GTPS #Embolization
March 13, 2025 at 12:00 PM
1/6 🚨 64.5% of patients with great trochanteric pain syndrome (GTPS) showed improvement with LFCA embolization, as per the latest study results.
Check out this new study from CVIR on managing hip pain when conservative treatments fail👇
#GTPS #Embolization
Check out this new study from CVIR on managing hip pain when conservative treatments fail👇
#GTPS #Embolization
5/6 📌 Conclusion: A tailored approach considering angiographic findings and clinical progression can be important when managing concurrent NCS and PCS.
🔗 Full study: doi.org/doi:10.1186...
#VascularSurgery #PatientCare #ClinicalGuidelines #MedTwitter
🔗 Full study: doi.org/doi:10.1186...
#VascularSurgery #PatientCare #ClinicalGuidelines #MedTwitter
March 9, 2025 at 5:36 PM
5/6 📌 Conclusion: A tailored approach considering angiographic findings and clinical progression can be important when managing concurrent NCS and PCS.
🔗 Full study: doi.org/doi:10.1186...
#VascularSurgery #PatientCare #ClinicalGuidelines #MedTwitter
🔗 Full study: doi.org/doi:10.1186...
#VascularSurgery #PatientCare #ClinicalGuidelines #MedTwitter
4/6 Results from four case scenarios demonstrate a nuanced decision-making process:
✅ Analyze angiographic findings.
✅ Tailor stenting based on the patient's vascular characteristics and symptoms.
✅ Different scenarios validate the personalized approach towards NCS & PCS.
✅ Analyze angiographic findings.
✅ Tailor stenting based on the patient's vascular characteristics and symptoms.
✅ Different scenarios validate the personalized approach towards NCS & PCS.
March 9, 2025 at 5:36 PM
4/6 Results from four case scenarios demonstrate a nuanced decision-making process:
✅ Analyze angiographic findings.
✅ Tailor stenting based on the patient's vascular characteristics and symptoms.
✅ Different scenarios validate the personalized approach towards NCS & PCS.
✅ Analyze angiographic findings.
✅ Tailor stenting based on the patient's vascular characteristics and symptoms.
✅ Different scenarios validate the personalized approach towards NCS & PCS.
3/6 Key considerations:
🔹 NCS isn't a contraindication for ovarian vein embolization.
🔹 Decisions on simultaneous vs. sequential stenting rely on:
- Detailed angiographic results
- Patient's clinical progression
#OvarianVeinEmbolization #InterventionalRadiology
🔹 NCS isn't a contraindication for ovarian vein embolization.
🔹 Decisions on simultaneous vs. sequential stenting rely on:
- Detailed angiographic results
- Patient's clinical progression
#OvarianVeinEmbolization #InterventionalRadiology
March 9, 2025 at 5:36 PM
3/6 Key considerations:
🔹 NCS isn't a contraindication for ovarian vein embolization.
🔹 Decisions on simultaneous vs. sequential stenting rely on:
- Detailed angiographic results
- Patient's clinical progression
#OvarianVeinEmbolization #InterventionalRadiology
🔹 NCS isn't a contraindication for ovarian vein embolization.
🔹 Decisions on simultaneous vs. sequential stenting rely on:
- Detailed angiographic results
- Patient's clinical progression
#OvarianVeinEmbolization #InterventionalRadiology
2/6 Management insights:
🔍 Analyses of renocaval pressure gradients often yield inconclusive results.
🔍 Evaluation of the left renal vein waveform can enhance diagnostic clarity.
🔍 "Test PTA" showing a balloon waist helps uncover significant stenosis.
#VascularHealth #IR
🔍 Analyses of renocaval pressure gradients often yield inconclusive results.
🔍 Evaluation of the left renal vein waveform can enhance diagnostic clarity.
🔍 "Test PTA" showing a balloon waist helps uncover significant stenosis.
#VascularHealth #IR
March 9, 2025 at 5:36 PM
2/6 Management insights:
🔍 Analyses of renocaval pressure gradients often yield inconclusive results.
🔍 Evaluation of the left renal vein waveform can enhance diagnostic clarity.
🔍 "Test PTA" showing a balloon waist helps uncover significant stenosis.
#VascularHealth #IR
🔍 Analyses of renocaval pressure gradients often yield inconclusive results.
🔍 Evaluation of the left renal vein waveform can enhance diagnostic clarity.
🔍 "Test PTA" showing a balloon waist helps uncover significant stenosis.
#VascularHealth #IR
1/6 🚨 Discussing optimal strategies for managing nutcracker syndrome (NCS) and pelvic congestion syndrome (PCS)!
Dive into the latest insights from CVIR Endovascular on treatment algorithms through four unique case studies 👇
#NutcrackerSyndrome #PelvicCongestionSyndrome
Dive into the latest insights from CVIR Endovascular on treatment algorithms through four unique case studies 👇
#NutcrackerSyndrome #PelvicCongestionSyndrome
March 9, 2025 at 5:36 PM
1/6 🚨 Discussing optimal strategies for managing nutcracker syndrome (NCS) and pelvic congestion syndrome (PCS)!
Dive into the latest insights from CVIR Endovascular on treatment algorithms through four unique case studies 👇
#NutcrackerSyndrome #PelvicCongestionSyndrome
Dive into the latest insights from CVIR Endovascular on treatment algorithms through four unique case studies 👇
#NutcrackerSyndrome #PelvicCongestionSyndrome
